Hanan Sboul’s Post

#portfolionews I Our portfolio company Xeltis has received Investigational Device Exemption (IDE) approval from FDA - La Administración de Alimentos y Medicamentos for initiation of US pivotal #trial for aXessTM, its restorative vascular access conduit. 👏 👉 Full details here https://bit.ly/4c3uSsf 🎯 aXess is a restorative conduit that enables the creation of a new, permanent, living vessel for #hemodialysis vascular access, combining the #safety and patency of an arteriovenous fistula (AVF), with the speed to treatment of an arteriovenous graft (AVG). The aXess vascular access conduit offers an improved dialysis patient experience and avoids the frequent reinterventions and complications, such as infections, faced by many renal disease patients. 🔬 The #US-based pivotal trial follows strong 12-month data from the first-in-human trial in Europe in comparison to hemodialysis vascular access solutions. aXess is also undergoing an EU pivotal trial, recruiting up to 110 patients in nine #EU countries. #FDA #VascularAccess #IDE #hemodialysis #renal #vc #innovation #MedicalInnovation #Healthcare #RenalCare #FDAApproval #ClinicalTrials 

Respiratory and nasal challenge tests in a clinical trial can expedite drug development by demonstrating target engagement and efficacy prior to patient exposure in a relatively small study in a well-controlled environment. In addition, bioavailability assessment during a nasal allergen assessment is essential for drugs intranasally administered. Learn about the merits and limitations of various respiratory and nasal challenge tests: https://lnkd.in/eXNC4pAC https://lnkd.in/gGJbzGP #RespiratoryChallenge #AllergenChallenge #RespiratoryCenterOfExcellence #BelfastClinic

PGX & Reducing Adverse Drug Reactions: Adverse drug reactions can occur when an individual's genetic makeup interacts negatively with a medication. Pharmacogenetics allows healthcare professionals to identify patients who may have an increased risk of adverse reactions to certain drugs. With this knowledge, doctors can adjust dosage, prescribe alternative medications, or provide closer monitoring, reducing the likelihood of adverse events and improving patient safety. Reach out to us today if you share this concern or would like to learn more about how Telos PGX can assist your community. Below are some of the most common ADRs affecting Medicare recipients. I •GI Issues •Cognitive effects •Orthostatic Hypotension •Falls •Unusual Liver/Kidney tests #telos #telospgx #pgx #pharmacogenetics #medicare #medicaid #texas #snf #skillednursingfacility #txhca

Adverse Drug Reactions can be avoided with proper analysis and professional guidance.

🚨 New Counselling Tool for High-Cost Medicines 🚨 The Council of Therapeutic Advisory Groups (CATAG) have released the High-cost Medicines in Public Hospitals Consumer Counselling Tool, built on their Navigating High-Cost Medicines Guiding Principles and designed to support Medicines and Therapeutics Advisory Committees in promoting the quality use of high-cost medicines with consumers. 💡 How can this tool help? It’s aimed at hospital-based health professionals to encourage shared decision-making with patients when discussing high-cost medicines. Written in plain language, the tool explains everything consumers need to know about the approval process for high-cost medicines in public hospitals. Learn more about this important initiative and download the resource here: https://buff.ly/3Yku9i3

Today marks the start of #GlobalBiosimilarsWeek, the health awareness week for biosimilar medicines. Join us as patients, healthcare providers, regulators and industry professionals discuss ways of Advancing Access to Biosimilars. Learn more, download the social media toolkit, and register for the webinar at globalbiosimilarsweek.org. #GBW24 #biosimilar #biosimilars #BiosimilarsAccess IGBA - International Generic and Biosimilar medicines Association

Ketamine abuse presents unique challenges, but with reliable testing methods, we can make informed decisions that support long-term recovery. As healthcare professionals, we understand the critical role that accurate drug testing plays in providing effective treatment and ensuring patient safety. At Ovus Medical, we offer Ketamine Drug Test Strips that deliver fast, accurate, and reliable results. Designed with a high sensitivity threshold and easy-to-use format, our test strips empower you to detect ketamine use swiftly and take necessary action. Strips as low as $0.59 each! By incorporating Ovus Medical’s Ketamine Drug Test Strips into your practice, you can: • Monitor Patient Progress: Regular testing helps you track patient adherence to treatment plans and spot any relapses early. • Ensure Safe Medication Use: Avoid potential complications by confirming that ketamine does not interact adversely with other medications your patients may be taking. • Support Recovery: Accurate testing fosters a trustworthy relationship between healthcare providers and patients, creating a supportive environment essential for recovery. Visit our website to learn more about our innovative Ketamine Drug Test Strips: https://lnkd.in/edZVbJu8 For customer support or bulk pricing: Email us at BH@OvusMedical.com or Give us a call at 1-800-921-8241 . . . #medicalsupplies #lowestprice #Healthcare #SubstanceAbuse #KetamineTesting #OvusMedical #Recovery

Ketamine abuse presents unique challenges, but with reliable testing methods, we can make informed decisions that support long-term recovery. As healthcare professionals, we understand the critical role that accurate drug testing plays in providing effective treatment and ensuring patient safety. At Ovus Medical, we offer Ketamine Drug Test Strips that deliver fast, accurate, and reliable results. Designed with a high sensitivity threshold and easy-to-use format, our test strips empower you to detect ketamine use swiftly and take necessary action. Strips as low as $0.59 each! By incorporating Ovus Medical’s Ketamine Drug Test Strips into your practice, you can: • Monitor Patient Progress: Regular testing helps you track patient adherence to treatment plans and spot any relapses early. • Ensure Safe Medication Use: Avoid potential complications by confirming that ketamine does not interact adversely with other medications your patients may be taking. • Support Recovery: Accurate testing fosters a trustworthy relationship between healthcare providers and patients, creating a supportive environment essential for recovery. Visit our website to learn more about our innovative Ketamine Drug Test Strips: https://lnkd.in/eQ4TYrcM For customer support or bulk pricing: Email us at BH@OvusMedical.com or Give us a call at 1-800-921-8241 . . . #medicalsupplies #lowestprice #Healthcare #SubstanceAbuse #KetamineTesting #OvusMedical #Recovery

25,000 people to benefit after NICE recommends new ulcerative colitis treatment! 🙏 Thousands of people could be set to benefit after NICE recommended a new one-a-day pill as an option for treating severe ulcerative colitis. NICE’s final guidance on etrasimod (also known as Velsipity and made by Pfizer) was published on the same day that the treatment was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA). Just over 25,000 people in England are eligible to receive the new treatment, which was evaluated using a simpler technology appraisal process. As a result, the final guidance was available up to eight weeks faster than would have been the case under standard process. Etrasimod is recommended for people aged 16 and over with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or biological treatment > https://ow.ly/jaOS50R1TJz #UlcerativeColitis #Colitis #Colon #Medication #Treatment

Daily Critical Care Pearls #212: Does tailoring drug-drug interaction alerts to the ICU setting reduce the number of high-risk drug combinations administered? 👇👇👇 Full article can be accessed through: https://lnkd.in/dEVdDPEZ #criticalcare #clinicalpharmacy #medicine #pearls